HuGE Literature Finder
Records
1
-
30
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. Balkan medical journal 2021 Nov 38 (6): 382-391. Kahraman Çetin Nesibe, Erdo?du ?brahim Halil, Bozkurt Emin, Meteo?lu ?brah |
| Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancer. Cancer medicine 2021 Jun . Zhang Yujun, Xiong Liwen, Xie Fangfang, Zheng Xiaoxuan, Li Ying, Zhu Lei, Sun Jiayu |
| Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung. Cell death & disease 2021 May 12 (5): 472. Song Zhengbo, Liu Yueping, Cheng Guoping, Chang Lianpeng, Yu Zicheng, Chen Ming, Chen Ga |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Implementation of clinical sequencing for molecular profiling in patients with advanced cancer. Cancer biomarkers : section A of Disease markers 2021 Apr . Fukui Tomoya, Sakai Kazuko, Sasaki Jiichiro, Kakegawa Mikiko Ishihara, Igawa Satoshi, Mitsufuji Hisashi, Takeda Masayuki, Takahama Takayuki, Nakagawa Kazuhiko, Nishio Kazuto, Naoki Katsuhi |
| Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field. Lung cancer (Amsterdam, Netherlands) 2021 Apr 154 131-141. Volckmar Anna-Lena, Christopoulos Petros, Kirchner Martina, Allgäuer Michael, Neumann Olaf, Budczies Jan, Rempel Eugen, Horak Peter, Glade Julia, Goldschmid Hannah, Seker-Cin Huriye, Brandt Regine, Kriegsmann Mark, Leichsenring Jonas, Winter Hauke, Faehling Martin, Fischer Jürgen R, Heußel Claus Peter, Herth Felix, Brummer Tilman, Fröhling Stefan, Schirmacher Peter, Thomas Michael, Endris Volker, Penzel Roland, Kazdal Daniel, Bochtler Tilmann, Stenzinger Albrec |
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer 2021 Apr . Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya |
| Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients with Non-Small Cell Lung Cancer. Chest 2021 Apr . Roosan Moom R, Mambetsariev Isa, Pharaon Rebecca, Fricke Jeremy, Husain Hatim, Reckamp Karen L, Koczywas Marianna, Massarelli Erminia, Bild Andrea H, Salgia Ra |
| Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study. Lung cancer (Amsterdam, Netherlands) 2021 Mar 155 20-27. Wang Wenxian, Xu Chunwei, Chen Huafei, Jia Jinhao, Wang Liping, Feng Huijing, Wang Hong, Song Zhengbo, Yang Nong, Zhang Yongcha |
| Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort. BMC cancer 2021 Feb 21 (1): 176. Zhu Donglin, Cao Dan, Shen Minghong, Lv Jinghu |
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors. The oncologist 2020 Dec . Takeda Masayuki, Takahama Takayuki, Sakai Kazuko, Shimizu Shigeki, Watanabe Satomi, Kawakami Hisato, Tanaka Kaoru, Sato Chihiro, Hayashi Hidetoshi, Nonagase Yoshikane, Yonesaka Kimio, Takegawa Naoki, Okuno Tatsuya, Yoshida Takeshi, Fumita Soichi, Suzuki Shinichiro, Haratani Koji, Saigoh Kazumasa, Ito Akihiko, Mitsudomi Tetsuya, Handa Hisashi, Fukuoka Kazuya, Nakagawa Kazuhiko, Nishio Kazu |
| Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418). Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, de Lima Vladmir Cordei |
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy. Translational lung cancer research 2020 Dec 9 (6): 2367-2379. Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data analysis. Oncology letters 2020 Sep 20 (3): 2266-2272. Chang Nijia, Duan Jingjing, Wang Lingxiong, Dong Zhouhuan, Liu Zhefe |
| Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non-small-cell Lung Cancer. Clinical lung cancer 2020 Sep . Zhu Yan-Juan, Qu Xin, Zhan Dan-Dan, Chen Hui-Hui, Li Hai-Peng, Liu Li-Rong, Chen Xian, Liu Yi-Hong, Li Yong, Bai Jian-Ping, Ye Sheng, Zhang Hai- |
| The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA. Journal of clinical medicine 2020 Aug 9 (8): . Chang Won Jin, Sung Jae Sook, Lee Sung Yong, Kang Eun Joo, Kwon Nak-Jung, Kim Hae Mi, Shin Sang Won, Choi Jung Yoon, Choi Yoon Ji, Kim Ju Won, Park Kyong Hwa, Kim Yeul Ho |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
| Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution. Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
| Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort. Cancer management and research 2020 12 7427-7437. Shen Hai-Bo, Li Jie, Yao Yuan-Shan, Yang Zhen-Hua, Zhou Yin-Jie, Chen Wei, Hu Tian-J |
| Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer. Cancer genomics & proteomics 0 17 (5): 597-603. Chevallier Mathieu, Tsantoulis Petros, Addeo Alfredo, Friedlaender Al |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: